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The bipartite structure of the tRNA m1A58
methyltransferase from S. cerevisiae is conserved in humans
SARAH OZANICK, ANNETTE KRECIC, JOSHUA ANDERSLAND,1 and JAMES T. ANDERSON
Department of Biological Sciences, Marquette University, Milwaukee, Wisconsin 53201, USA

ABSTRACT
Among all types of RNA, tRNA is unique given that it possesses the largest assortment and abundance of modified nucleosides.
The methylation at N1 of adenosine 58 is a conserved modification, occurring in bacterial, archaeal, and eukaryotic tRNAs. In
the yeast Saccharomyces cerevisiae, the tRNA 1-methyladenosine 58 (m1A58) methyltransferase (Mtase) is a two-subunit
enzyme encoded by the essential genes TRM6 (GCD10) and TRM61 (GCD14). While the significance of many tRNA modifications is poorly understood, methylation of A58 is known to be critical for maintaining the stability of initiator tRNAMet in yeast.
Furthermore, all retroviruses utilize m1A58-containing tRNAs to prime reverse transcription, and it has been shown that the
presence of m1A58 in human tRNA3Lys is needed for accurate termination of plus-strand strong-stop DNA synthesis during HIV1 replication. In this study we have identified the human homologs of the yeast m1A Mtase through amino acid sequence
identity and complementation of trm6 and trm61 mutant phenotypes. When coexpressed in yeast, human Trm6p and Trm61p
restored the formation of m1A in tRNA, modifying both yeast initiator tRNAMet and human tRNA3Lys. Stable hTrm6p/hTrm61p
complexes purified from yeast maintained tRNA m1A Mtase activity in vitro. The human m1A Mtase complex also exhibited
substrate specificity—modifying wild-type yeast tRNAiMet but not an A58U mutant. Therefore, the human tRNA m1A Mtase
shares both functional and structural homology with the yeast tRNA m1A Mtase, possessing similar enzymatic activity as well as
a conserved binary composition.
Keywords: modified nucleoside; methyltransferase; tRNA modification; HIV-1 replication

INTRODUCTION
The cellular translational machinery is capable of converting nucleotide sequences into amino acid chains because of
the distinctive structure of transfer RNA (tRNA) molecules,
making tRNAs crucial for proper gene expression and
protein biosynthesis. In order to reach their mature
forms, tRNAs undergo a series of post-transcriptional processing events, including end trimming, splicing of intervening sequences, CCA addition to the 30 -end, and base or
ribose modification (Hopper and Phizicky 2003). Modified
nucleosides have been detected in most cellular RNAs;
however, tRNAs are more abundantly and diversely modified than are other RNAs (Björk 1995). In many cases, the
exact role modified nucleosides play in tRNA function
remains unknown due to the finding that tRNAs lacking
modified nucleotides retain their normal function. For
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example, deletion of genes from the yeast Saccharomyces
cerevisiae encoding TRM2 (generates m5U54), TRM4 (generates m5C34, 40, 48, 49), or PUS6 (generates C31) exhibit
no visible growth defect (Wu et al. 1998; Nordlund et al.
2000; Ansmant et al. 2001).
The modified nucleoside 1-methyladenosine (m1A) is
found at position 58 in tRNAs from organisms in each of
the three domains of life. In S. cerevisiae, 23 of the 34 tRNA
sequences that have been determined contain m1A58
(Sprinzl and Vassilenko 2005), and modification of
tRNAGln(CTG) has recently been discovered by using a
microarray (Hiley et al. 2005). We previously showed that
a two-subunit methyltransferase (Mtase) encoded in yeast
by the essential TRM6 (GCD10) and TRM61 (GCD14)
genes is responsible for this post-transcriptional base modification (Anderson et al. 2000). In keeping with the conventional nomenclature of tRNA modification enzymes
from yeast, GCD10 and GCD14 are now referred to as
TRM6 and TRM61, respectively (Kadaba et al. 2004).
While structural and functional homologs of Trm61p
have been identified in Archaea and Eubacteria (Bujnicki
2001; Gupta et al. 2001; Droogmans et al. 2003; Roovers
et al. 2004; Varshney et al. 2004), homologs of Trm6p have
not been found in the sequenced genomes of organisms
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from these same domains (Bujnicki 2001). It has been
suggested that a gene duplication of TRM61 appeared
early in eukaryotic evolution to yield the progenitor of
the TRM6 gene that is presently found in eukaryotes
(Bujnicki 2001).
Previously, we reported that tRNAs from a yeast strain
bearing a trm6 deletion (trm6D) lacked m1A58 and that its
absence led to the selective reduction of steady-state initiator methionine tRNA (tRNAiMet) (Anderson et al. 1998).
Accordingly, the lethality of this defect is suppressed by the
overexpression of tRNAiMet (Anderson et al. 1998). Mutations in TRM61 that were predicted to interfere with
S-adenosylmethionine (AdoMet) binding exhibited a null
phenotype but did not disrupt formation of enzyme complexes. In addition, purified Trm61p alone failed to bind
tRNA in an in vitro assay, leading to the hypothesis that
Trm6p binds the tRNA substrate while Trm61p binds
AdoMet and catalyzes the N1-methylation of adenosine 58
in tRNA (Anderson et al. 2000).
Along with the function of m1A58 in tRNAiMet stability,
it has been reported that m1A58 in human tRNA3Lys is
important for efficient replication of human immunodeficiency virus type 1 (HIV-1) (Gilboa et al. 1979; Burnett and
McHenry 1997; Renda et al. 2001). All retroviruses contain
a primer binding site (PBS) of 18 nucleotides that is complementary to the 30 -end of a host tRNA, allowing the
tRNA to be used as a primer for  strand DNA synthesis
and as a template for replication of the PBS on the +
strand. Past work has shown that the presence of m1A58
leads to proper termination of + strand strong-stop DNA
synthesis during HIV replication, presumably because m1A
can not base pair correctly (Burnett and McHenry 1997;
Renda et al. 2001). The significance of m1A58 is further
demonstrated by in vivo studies in which HIV replication is
inhibited in T cells expressing tRNA3Lys with A58 changed
to U (Renda et al. 2001, 2004). Since tRNA3Lys is directly
involved in HIV replication and because HIV exhibits a
preference for this tRNA (Das et al. 1995; Wakefield et al.
1995, 1996; Moore et al. 2004), preventing the modification
of tRNA3Lys has been suggested as a possible anti-HIV
therapy (Burnett and McHenry 1997; Renda et al. 2001,
2004). While m1A58 is essential for yeast viability, a rat
mammary adenocarcinoma with reduced m1A in tRNA has
been described, demonstrating that decreased m1A methyltransferase activity is not lethal (Salas et al. 1982). Consequently, the human m1A58 methyltransferase may be one
possible target for an HIV therapeutic agent.
Having established the identity of the yeast m1A58 Mtase
in previous work, we sought to exploit the yeast system to
expand our studies to include the apparent human homolog. Because this enzyme may represent a target for HIV
treatment, it is important to determine if the human
homologs of the yeast enzyme encode a functional m1A58
Mtase. Here we show the results of several experiments that
reveal that human TRM6 (hTRM6) and human TRM61
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(hTRM61) together encode an active tRNA m1A Mtase
capable of modifying both yeast tRNAiMet and human
tRNA3Lys in vivo. In addition, we report that hTrm6p/
hTrm61p complexes purified from yeast modify an in
vitro transcribed tRNA. Furthermore, we provide evidence
that the human enzyme synthesizes m1A at position 58.
The human m1A58 methyltransferase is now the fourth
tRNA methyltransferase from humans to be cloned and
characterized, and only the second to be purified (Liu
and Straby 2000; Alexandrov et al. 2002; Brule et al. 2004).
RESULTS
Identification of human homologs of the yeast
tRNA m1A methyltransferase
The presence of m1A in tRNA from the three kingdoms of
life (Björk 1995) suggested that an enzyme with homologous function exists in all organisms, including humans.
We began our search for the human homolog by conducting BLAST searches of the human EST database (Altschul
et al. 1990) using the polypeptide sequences of Trm6p
(previously Gcd10p) and Trm61p (previously Gcd14p).
Several EST clones containing partial sequences that
encoded proteins with significant similarity to Trm6p or
Trm61p were identified (data not shown). The most complete human cDNA identified contained an open reading
frame (ORF) with significant similarity (20% identity) to
yeast Trm6p, with the greatest homology found near the
C terminus (Fig. 1A). Of particular note is a conserved dipeptide near the C terminus, consisting of histidine 431 and
proline 432. In yeast it has been found that substitution of
proline 431 by arginine or leucine (trm6-504 or trm6-505,
respectively) (J. Anderson, unpubl.) causes temperature-sensitive growth at 36 C, suggesting this conserved region has
functional importance. This histidine/proline dipeptide is
found in the sequence of the apparent human homolog as
well as in putative homologs from other eukaryotes such as
Mus musculus and Drosophila melanogaster (Fig. 1A; Bujnicki
2001). In the case of Trm61p, there is 30% identity overall
with the apparent human homolog (Fig. 1B). In addition, the
hTrm61p sequence shares identity with the Trm61p in specific
regions that represent known motifs common among
S-adenosylmethionine–dependent methyltransferases (Kagan
and Clarke 1994; Fauman et al. 1999). From these preliminary structural comparisons, two cDNAs were obtained for
further investigation.
To study the function of hTrm6p, a cDNA (accession
no. AK000613, plasmid p198) containing the full-length
hTRM6 ORF was obtained. When compared to the human genome, this cDNA has two consecutive nucleotide
changes, resulting in the substitution of glycine for glutamic acid at position 299 (Fig. 1A). As the amino acid at this
position is not conserved, this substitution is not likely to
affect hTrm6p function. A plasmid containing a full-length
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FIGURE 1. Eukaryotic orthologs of Trm6p and Trm61p. (A) Alignment of predicted polypeptide sequences of Trm6p from Homo sapiens (H.s.)
with homologous proteins from Mus musculus (M.m.), Drosophila melanogaster (D.m.), and Saccharomyces cerevisiae (S.c.). The arrowhead
highlights proline 431, the amino acid changed in the temperature-sensitive stains trm6-504 and trm6-505. The asterisk indicates the substitution
of glycine for glutamic acid at amino acid 299. (B) Alignment of Trm61p from H.s. with homologous proteins from eukaryotes (M.m, D.m., S.c.)
as in A. The alanine at position 66, which is found as valine in sequence from the human genome, is indicated by the asterisk. Shading designates
the amino acids conserved between two or more homologs.

hTRM61 cDNA (plasmid p218) was obtained. When this
cDNA was sequenced and the sequence was compared with
both the human genome and another cDNA (BC010167),
two nucleotide changes were noted. Only one of these
changes alters the amino acid sequence, causing the substitution of alanine for valine at position 66 (Fig. 1B). Given
the presence of alanine in this same position in the Trm61p
homolog from D. melanogaster (Fig. 1B; Bujnicki 2001), it is
unlikely that this change would alter hTrm61p function.
Complementation of temperature-sensitivity
in yeast mutants by hTRM6/hTRM61
Temperature-sensitive trm6 and trm61 mutants exhibit a
reduced steady-state level of tRNAiMet, which we proposed
and demonstrated is due to a lack of m1A58 that leads to
pre-tRNAiMet instability and degradation (Anderson et al.
1998; Calvo et al. 1999; Kadaba et al. 2004). These mutant
strains grow at 26 C but are unable to grow at 36 C. Two
yeast strains bearing point mutations, trm6-504 or trm61-2
(Y190 or Hm296, respectively), were used to determine
whether expression of hTRM6 and/or hTRM61 could complement their temperature-sensitive growth defects. Both
hTRM6 and hTRM61 cDNA sequences were amplified by
PCR and cloned into pESC-URA (Stratagene), a vector that
allows for the individual or simultaneous expression of two

exogenous proteins in yeast using the galactose-inducible/
glucose-repressible GAL1-10 promoter. A TRM6 strain
(Y200) was transformed with pESC-URA, while trm6-504
was transformed with pESC-URA or pESC-URA containing hTRM6 (p244), or both hTRM6 and hTRM61 (p230).
Transformants were grown in synthetic complete liquid
media supplemented with galactose and raffinose (SCgal/
raf) and lacking uracil to select for plasmids. Serial dilutions of these cultures were spotted onto selective SCgal/raf
or SC glucose plates at permissive (26 C) and nonpermissive (36 C) temperatures. While colonies readily formed in
all of the transformants at the permissive temperature,
colony formation at the nonpermissive temperature was
seen only for the wild-type TRM6 strain or the trm6-504
mutant strain containing both hTRM6 and hTRM61 (Fig. 2A).
Expression of hTRM6 alone was unable to complement the trm6-504 temperature-sensitive growth defect at
36 C, demonstrating that hTrm6p is likely to be insufficient for m1A58 formation in yeast tRNAs. Moreover, this
result provided the first indication that hTRM6 and
hTRM61 together encode an active tRNA m1A Mtase. On
SC glucose media (pESC-URA repressing condition), only
the wild-type TRM6 strain exhibited growth at 36 C,
demonstrating that complementation is dependent on
expression of hTRM6 and hTRM61 (S. Ozanick and J.
Anderson, unpubl.).
www.rnajournal.org
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(see below and Table 1). Therefore, the
growth seen for the trm61-2 strain expressing hTrm61p is not due to a detectable
increase in the amount of m1A in total
tRNA.

Human Trm6p/Trm61p expression
restores m1A formation in
tRNA in vivo
Complementation of the temperaturesensitivity exhibited by trm6-504 or
FIGURE 2. hTrm6p/hTrm61p expression in yeast complements the temperature-sensitivity of trm61-2 mutants can occur by increasyeast strains trm6-504 and trm61-2. (A) A trm6-504 strain was transformed with pESC-URA
ing the copy number of the IMT genes,
(shown as trm6-504) or pESC-URA containing hTRM6 (p244) or hTRM6/hTRM61 (p230).
Met
These transformants and an isogenic wild-type strain bearing pESC-URA (shown as TRM6) encoding tRNAi , or LHP1, encoding
0
were grown to saturation at room temperature in liquid medium, SCgal/raf lacking uracil. the tRNA 3 -end processing factor
Serial 10-fold dilutions of these cultures were spotted (5 mL) onto SCgal/raf plates lacking Lhp1p (Yoo and Wolin 1997; Anderson
uracil and incubated at the indicated temperature for 2–4 d. (B) A trm61-2 strain was
et al. 1998; Calvo et al. 1999). This
transformed with pESC-URA (shown as trm61-2) or with plasmids containing hTRM61
(p231), hTRM6/hTRM61 (p230), or TRM61 (pRC56). Growth of the transformants on genetic complementation results in an
SCgal/raf plates was as described in A at the indicated temperatures for 2–4 d.
increase in mature tRNAiMet but does
not restore tRNA m1A formation in a
strain lacking a functional m1A Mtase
(Anderson et al. 1998). To determine whether complemenSimilarly, strain trm61-2 (Hm296) was transformed with
tation of trm6-504 and trm61-2 mutants by expression of
a single-copy plasmid bearing TRM61 (pRC56) (Calvo
the cloned human cDNAs is accompanied by formation of
et al. 1999), pESC-URA or pESC-URA containing
m1A in tRNA and not merely an increase in tRNAiMet
hTRM61 (p231), or both hTRM6 and hTRM61 (p230)
levels, we determined the modified nucleoside content of
and tested for growth at permissive and nonpermissive
total tRNA from a number of strains grown in selective
temperatures on SCgal/raf plates. In each case, colonies
SCgal/raf at 30 C (Fig. 3; Table 1). Total tRNA was purified
formed at the permissive temperature (Fig. 2B). At the
from the wild-type (Y200) strain containing pESC-URA,
nonpermissive temperature, the formation of colonies by
the trm6-504 mutant containing pESC-URA, and the trm6transformants expressing both hTRM6 and hTRM61, albeit
504 mutant expressing hTRM6/hTRM61 (p230). The quansomewhat smaller than TRM61 transformants, indicated
titative determination of m1A and m5C levels was accomthat expression of hTrm6p and hTrm61p partially compleplished by normalizing the percentage area of the m1A or
ments the trm61-2 temperature-sensitive growth defect.
Interestingly, a trm61-2 mutant expressing hTRM61 alone
exhibited some growth at 36 C (Fig. 2B). One possible
TABLE 1. HPLC analysis of tRNA
explanation for the low level of complementation of
Relative m5C
Relative m1A
trm61-2 by hTrm61p is that this subunit functions to
some degree as an m1A Mtase in yeast independently of
%
%
hTrm6p. However, Western blot analysis has illustrated
Yeast strain/plasmid
m1A/C Wild type m5C/C Wild type
that hTrm61p is expressed at very low levels in the absence
Wild type/pESC-URA 0.29
100
0.22
100
of hTrm6p (S. Ozanick and J. Anderson, unpubl.). This is
trm6-504/pESC-URA 0.02
6
0.21
98
not unprecedented, as a similar situation exists for memtrm6-504/hTRM6/
bers of another two-subunit tRNA methyltransferase found
hTRM61
0.31
107
0.22
100
trm61-2/TRM61
0.21
100
0.16
100
in yeast, Trm8p and Trm82p. In a trm82 deletion strain,
trm61-2/pESC-URA
0.02
10
0.16
100
the level of Trm8p is reduced, even though TRM8 mRNA
trm61-2/hTRM61
0.02
10
0.15
94
levels do not change (Alexandrov et al. 2005). Alternatively,
trm61-2/hTRM6/
hTrm61p may be capable of interacting with Trm6p to
hTRM61
0.15
71
0.18
113
create an inefficient, yet active, enzyme. To address the
1
The quantitative determination of m A and 5-methylcytidine (m5C)
possibility that hTrm61p restores some m1A formation in
levels was done by normalizing the percentage area of the m1A
tRNA, total tRNA was purified from the trm61-2 strain
and m5C peaks to the percentage area of the pseudouridine (C)
peak in each sample. The amount of m1A and m5C found in the
expressing hTrm61p alone and analyzed by HPLC. The
1
wild-type strain containing only pESC-URA and the trm61-2 strain
level of m A in this strain was not found to be greater
complemented with TRM61 was set at 100%.
than that of the trm61-2 strain containing only pESC-URA
1284
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FIGURE 3. Expression of hTrm6p/hTrm61p restores wild-type levels of m1A in tRNA. Total tRNA purified from wild-type yeast (Y200)
containing pESC-URA (A), trm6-504 (Y190) containing pESC-URA (B), and trm6-504 (Y190) containing hTRM6/hTRM61(p230) (C) was
digested to single nucleosides and analyzed by HPLC. The absorbance at 254 nm (AU254) was measured and plotted against retention time
in minutes, as previously described (Anderson et al. 1998). For clarity, only a portion of the chromatograph—the region where m 1A,
5-methylcytidine (m5C), and 20 -O-methylcytidine (Cm) elute from the column—is shown.

5-methylcytidine (m5C) peaks with the percentage area of
the pseudouridine (C) peak in each sample. We chose to
use C to normalize the level of m1A and m5C because of its
ubiquitous nature (Grosjean et al. 1995), and formation of
C does not depend on the presence of m1A58 in tRNA
(Jiang et al. 1997). In contrast to the nearly equivalent
levels of m5C detected in tRNAs from all three strains
(Fig. 3A–C; Table 1), the trm6-504 mutant contained a
low level of m1A (6% compared with wild type) (Table 1;
Fig. 3B). Remarkably, the strain expressing hTRM6 and
hTRM61 exhibited a level of m1A similar to, if not slightly
higher than, the wild-type strain (107% vs. 100%) (Table 1;
Fig. 3A,C). It is possible that the slightly increased level
of m1A in this strain is due to modification of tRNAs
by hTrm6p/Trm61p that are not normally modified by
the yeast m1A Mtase (see below). The HPLC data corroborate our interpretation of the growth studies, demonstrating that expression of both hTRM6 and hTRM61
repairs the primary biochemical defect in the mutant
strain by restoring the formation of m1A in tRNA in
vivo. We propose from these observations that hTRM6
and hTRM61 encode proteins that form an active m1A
Mtase in yeast and that complementation of trm6-504
and trm61-2 mutants is through m1A58 formation in
tRNA.
To address whether the inability of hTRM6 and hTRM61
to fully complement a trm61-2 mutant is due to incomplete
restoration of m1A formation in tRNA, and to investigate
the partial complementation provided by hTrm61p alone,
we conducted the same HPLC analysis on tRNA purified
from trm61-2 strains containing pESC-URA, TRM61
(pRC56), hTRM61 alone (p231), or both hTRM6 and
hTRM61 (p230). Similar to what we had observed for
trm6-504, the level of m1A in tRNA from trm61-2 containing
only pESC-URA was found to be 10% of that found in

trm61-2 containing TRM61 on a plasmid (Table 1). Furthermore, the trm61-2 strain expressing only hTRM61 did
not contain an increased amount of m1A. Consistent
with the partial growth complementation of trm61-2
by hTRM6 and hTRM61 expression, we determined
that the m1A levels in tRNA isolated from that strain
were restored to only 71% of the wild-type control
(Table 1). This result, along with the complementation
analysis, indicates that partial complementation of
trm61-2 by hTRM6 and hTRM61 expression is due to
an inability of the human m1A Mtase to fully restore
m1A formation in the presence of a defective Trm61p
protein. Although this result is not understood and is
beyond the scope of this study, one possible explanation
is that inactive complexes form from interactions between yeast and human subunits. Alternatively, differences in hTrm6p/hTrm61p expression due to the strain
background may explain the full complementation seen
in the trm6-504 strain but only partial complementation
seen in the trm61-2 strain. It should also be noted that
the trm61-2 mutation is located in the start codon of
TRM61 and results in low levels of Trm61p (Calvo et al.
1999).

Modification of htRNA3Lys by hTrm6p/hTrm61p
in yeast
While HPLC analysis demonstrates that expression of
hTRM6 and hTRM61 leads to the formation of m1A in
tRNA in vivo, it does not reveal the m1A content of specific
tRNAs. To establish the identity of tRNAs modified by
hTrm6/hTrm61p, Northern blot analysis was performed.
A plasmid containing the htRNA3Lys gene was obtained as
a gift from Anders Byström (Umeå University, Umeå,
www.rnajournal.org
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Sweden). Three strains were created starting with a trm6
deletion (trm6D): trm6D bearing htRNA3Lys and pESCURA; trm6D bearing htRNA3Lys and pESC-URA containing
hTRM6 and hTRM61; and trm6D bearing htRNA3Lys and a
plasmid borne copy of yeast TRM6. Total RNA prepared
from these strains was subjected to acidic denaturing polyacrylamide gel electrophoresis (Varshney et al. 1991) and
transferred to a nylon membrane for Northern hybridization. The blot was probed for the presence of tRNAiMet,
htRNA3Lys, or tRNALeu(CAA) using a radiolabeled oligonucleotide (Fig. 4). Northern hybridization using the probe
specific for tRNAiMet illustrates that the mobility of this
tRNA from yeast containing either TRM6 or hTRM6 and
hTRM61 is altered compared with tRNA from the trm6D
strain (Fig. 4A). This mobility shift is presumably due to
the presence of m1A58 in this tRNA. Similarly, a change in
the mobility of htRNA3Lys is also seen when purified from
strains expressing either TRM6 or hTRM6 and hTRM61
(Fig. 4B), suggesting that both the yeast and human m1A
Mtases can modify this tRNA. Using a probe specific for
tRNALeu(CAA), a tRNA that does not contain m1A in
yeast, no difference was seen in the mobility of this tRNA
when purified from the strain expressing TRM6 or the
trm6D strain (Fig. 4C). However, a noticeable change was
seen in the migration of tRNALeu(CAA) from cells expressing hTRM6 and hTRM61 (Fig. 4C), suggesting that
hTrm6p/hTrm61p modifies this tRNA. It is known that
tRNALeu with an anti-codon consisting of an unknown

FIGURE 4. Modification of specific tRNAs by hTrm6p/hTrm61p.
Northern blot analysis of total RNA (5 mg) from a trm6D strain
expressing htRNA3Lys and either TRM6 (TRM6), pESC-URA (trm6D),
or hTRM6/hTRM61 (hTRM6/hTRM61). RNAs were separated on an
acidic, denaturing 5% acrylamide/bis-acrylamide, 19:1, sequencing gel
and transferred to a nylon membrane for hybridization with radiolabeled
probes specific for tRNAiMet (A), htRNA3Lys (B), or tRNALeu(CAA) (C).
Results were visualized by autoradiography.
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nucleotide followed by two adenosines is modified in
humans (Sprinzl and Vassilenko 2005), and the results of
this Northern blot analysis suggest that yeast tRNALeu(CAA)
is recognized as a substrate for modification by hTrm6p/
hTrm61p, but not the yeast m1A Mtase. This is consistent
with the small increase in m1A levels seen by HPLC analysis
of total tRNA isolated from a trm6D strain expressing both
hTRM6 and hTRM61 (Table 1). The ability of the human
m1A Mtase to modify yeast tRNALeu(CAA) while the yeast
enzyme does not implies that the yeast and human enzyme
have different substrate specificities. This knowledge should
be useful as we begin our studies aimed at defining protein
determinants required for substrate specificity of the yeast
and human enzymes.

hTrm6p/hTrm61p form a stable complex
when expressed in yeast
Since full complementation of trm6-504 or trm61-2
mutants required concomitant expression of hTrm6p and
hTrm61p, we wanted to determine whether the human
proteins also form complexes in vivo. To avoid the possibility of hTrm61p interacting with Trm6p (see above),
hTrm6p and hTrm61p were coexpressed in a trm6D strain
(Y146). Whole-cell extracts were prepared and the human
m1A Mtase complexes were purified under nondenaturing
conditions by affinity chromatography using anti-Flag
antibody (Materials and Methods), which is directed
against a single Flag epitope on hTrm61p. The purified
proteins were separated by SDS-PAGE and analyzed by
Coomassie blue staining (Fig. 5A). The Coomassie-stained
immunoprecipitate showed the presence of two predominant proteins with apparent molecular weights of 57 kDa
and 33 kDa. These apparent molecular weights are in good
agreement with the predicted molecular weights of
hTrm6p (55 kDa) and hTrm61p (31 kDa) based on the
cDNA sequences and the apparent molecular weights of
hTrm6p and hTrm61p detected by immunoblot analysis
(Fig. 5B). Western blot analysis of whole-cell extract and
the supernatant and pellet fractions following affinity purification was performed by using antibodies against a c-myc
epitope in hTrm6p and the Flag epitope in hTrm61p. This
analysis confirmed the presence of both hTrm6p and
hTrm61p in affinity-purified complexes, and we concluded
that hTrm6p was expressed to higher levels than was
hTrm61p in yeast due to its presence and hTrm61p absence
in the supernatant after affinity purification (Fig. 5B). The
specificity of our affinity purification procedure was demonstrated by the inability to detect an abundant ribosomal
protein, Pub2p (Anderson et al. 1993), in the immunoprecipitate (Fig. 5B) and the relative purity of the immunoprecipitate
as shown by Coomassie blue staining (Fig. 5A). It is clear from
these data that hTrm6p forms a stable complex with hTrm61p
in vivo.
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FIGURE 5. Purified hTrm6p/hTrm61p complexes possess tRNA (m1A) Mtase activity in vitro. Whole-cell extract (50 mg) from a trm6D strain
(Y146) grown in SCgal/raf and containing hTRM6 and hTRM61 (p230) was used as starting material for purification of Flag-tagged hTrm61p
using anti-Flag antibody bound to Sepharose beads (Sigma-Aldrich). Protein samples were separated by SDS-PAGE and stained with Coomassie
blue (A) or transferred to a nitrocellulose membrane for immunoblotting (B). (A) Lanes 1 and 2 contain 5 and 15 mL of purified enzyme
complex, respectively; lanes 3, 4, and 5 contain 0.25, 0.5, and 1.0 mg of BSA, respectively (included for quantitative purposes). (B) Lanes I (input)
and S (supernatant) contain 50 mg each of whole-cell extract or the supernatant after anti-Flag affinity purification, respectively. Lane P (pellet)
contains 0.5 mL (1/300) of the complex purified from 500 mL of yeast cells. hTrm6p, hTrm61p, and Pub2p were detected by ECL (Amersham)
using anti-c-myc, anti-Flag, and 2B1 monoclonal antibodies, respectively. Pub2p is an abundant yeast large ribosomal subunit protein, which
serves as a control for specificity. (C) Purified yeast or human Trm6p/Trm61p complexes were combined with S-adenosyl-[3H-methyl]methionine and in vitro transcribed tRNAiMet, A58U tRNAiMet, or 18S rRNA (Ambion) under optimal reaction conditions (see Materials and
Methods). The acid insoluble material was collected on nitrocellulose filters, dried, and counted by liquid scintillation. The amount of 3H-methyl
incorporated is shown as the average of two identical, independent reactions. Each reaction contained 15 nmol tRNA or 18S RNA substrate.

Purified hTrm6p/hTrm61p complexes
modify yeast tRNAiMet in vitro
We next examined whether the purified hTrm6p/hTrmp61p
complexes possessed m1A Mtase activity in vitro. Initially,
tRNAiMet purified to homogeneity from yeast cells lacking
a functional m1A Mtase was used as substrate for yeast
m1A Mtase complexes to optimize conditions for the methyltransferase activity in vitro (data not shown). To test the
ability of hTrm6p/hTrm61p complexes to modify tRNA,
yeast tRNAiMet was transcribed from a linearized plasmid
(HG300) using T7 RNA polymerase. Unlabeled T7 transcripts were renatured and combined with purified hTrm6p/
hTrm61p and S-adenosyl-L-[3H-methyl]methionine under
conditions optimized for m1A activity when using purified
yeast m1A Mtase. Both human and yeast Trm6p/Trm61p
complexes were able to incorporate 3H-methyl into the
tRNAiMet substrate, demonstrating the methyltransferase
activity of these enzymes. By using purified hTrm6p/

hTrm61p complexes from yeast, we observed the incorporation of 4.8 nmol of 3H-methyl in reactions containing 15 nmol
tRNA (Fig. 5C). Similar results (4.9 nmol incorporated) were
obtained when yeast Trm6p/Trm61p complexes were tested
(Fig. 5C), indicating that the human and yeast m1A Mtases
can modify approximately one third of the tRNAiMet substrate. Increasing the incubation time or concentration of
enzyme in a reaction did not lead to a significant increase in
the amount of substrate modified.
One caveat of these in vitro assays is the possibility of
modification at an adenosine in the tRNA at a position
other than A58 of the TCC loop. To address this limitation, a variant of tRNAiMet in which A58 was changed to
U58 was synthesized as a T7 transcript. While wild-type
tRNAiMet contained a significant amount of radioactive
methyl incorporated, the amount of 3H-methyl incorporated by both human and yeast Trm6p/Trm61p complexes
into the A58U mutant tRNAiMet was the same as seen for
a negative control, 18S rRNA (0.1 nmol) (Fig. 5C). This
www.rnajournal.org
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result illustrates not only the substrate specificity possessed
by both the human and yeast m1A Mtases but also their
ability to carry out position-specific modification of tRNA.
We conclude that the cDNAs identified do encode a
human tRNA m1A Mtase that functions to modify tRNAs
at position 58 of the TCC loop. This conclusion supports
the idea that the heteromeric structure of the yeast tRNA
m1A58 Mtase has been conserved throughout eukaryotic
evolution, further suggesting that subunit diversity is
important for the function of this enzyme in eukaryotes.
The exact role that each subunit plays in the formation of
m1A in tRNA is presently unknown, but studies are
ongoing to define specific enzymatic functions for each
subunit using the yeast enzyme as a model to provide
insight into how this and other eukaryotic tRNA m1A
Mtases function. Finding that the human cDNAs identified
in this study encode an active m1A Mtase that can replace a
nonfunctional yeast m1A Mtase presents the possibility of
using S. cerevisiae as a model system to identify potential in
vivo inhibitors of the human m1A Mtase, which ultimately
may have clinical significance in treating HIV-1 infections.

MATERIALS AND METHODS
Yeast strains and plasmid construction
The genotypes of yeast strains used in this work are listed in
Table 2, and the construction of strains Y190 and Y200 has been
described (Kadaba et al. 2004). Yeast transformations were done
as described (Ito et al. 1983). To clone hTRM6, the PCR was
used to amplify a 1511-bp fragment from AK000613, clone
KAT06232 (NEDO Human cDNA-Sequencing Project, Institute
of Medical Science, University of Tokyo), using oligos JA87 (50 GAACGCGTCGACAGAGTCAGACTCTGGGCATT) and JA88
(50 -CGGGGATCCATGGAGGGCTCAGGGGAG). After SalI/BamHI
digestion, the fragment was ligated into SalI/BamHI-digested pESCURA, a yeast epitope-tagging vector (Stratagene) to create plasmid
p244. A plasmid with both hTRM6 and hTRM61 was created by using oligos JA100 (50 -GACTAGTATGAGCTTCGTGGCATACGAG)
and JA110 (50 -CCATCGATGCCTGGGGTCTTGGTGG) to amplify

TABLE 2. Yeast strains used in this work
Name
H2457
Y200
Y190
Y146

Hm296

1288

Description
MAT , trm6-504, gcn2-101, his1-29,
ura3-52, ino1, (HIS4-lacZ, ura3-52)
MATa, TRM6, gcn2-101, his1-29,
ura3-52, ino1, (HIS4-lacZ, ura3-52)
MATa, trm6-504, gcn2-101, his1-29,
ura3-52m ubi1m (HIS4-lacZ, ura3-52)
MAT , trm6D, ura3-52, trp1, leu2D1,
his3D200, pep<HIS4, prb1D1’1.6,
can1, Gal+
MAT , trm61-2, ura3-52, gcn2-101, gcn3101, his1-29, ino1, (HIS4-lacZ, ura3-52)
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Reference
(Anderson
et al. 1998)
(Kadaba et al.
2004)
(Kadaba et al.
2004)
(Anderson
et al. 1998)
(Cuesta et al.
1998)

hTRM61 as a 900-bp PCR product from p218 (Dr. Michael
Tschudi, Yale University, New Haven, CT). After SpeI/ClaI digestion,
the fragment was ligated into SpeI/ClaI-digested p244. The resulting
plasmid was digested with ClaI, ClaI ends were blunt-ended using
Klenow, and the resulting product ligated to form p230. To construct
a plasmid containing only hTRM61, p230 was digested with SalI/
BamHI, the SalI/BamHI ends were blunt-ended using Klenow, and
the plasmid containing only hTRM61 was gel purified and ligated to
form p231.

Protein purification and detection
Purification of yeast Trm6p/Trm61p complexes was previously
described (Anderson et al. 2000) Flag-hTRM61p/hTRM6p complexes were affinity purified from yeast whole-cell extracts. All
steps in the enzyme purification process were carried out at 4 C.
A trm6D strain containing a high-copy plasmid bearing the IMT4
gene (Y146) (Anderson et al. 1998) and transformed with p230
was grown in 2 L of SCgal/raf (synthetic complete media supplemented with 5% galactose and 2% raffinose) lacking uracil and
leucine at 30 C to OD600 = 1. Cells were harvested by centrifugation at 7000g for 10 min, washed with 13 Tris buffered saline
(TBS), and resuspended in breaking buffer consisting of 13 TBS/
1 mM DTT/13 protease inhibitor cocktail (Roche), using 1 mL/g
wet-weight cells. Cells were broken by using a French press
(Thermo IEC) at a pressure of 20,000 psi. The whole-cell extract
was centrifuged at 30,000g for 20 min, and the supernatant was
then spun again at 75,000g for 20 min. The supernatant from this
centrifugation step (20 mL, 10 mg/mL whole-cell extract) was
incubated with anti-Flag M2-agarose affinity gel (Sigma) overnight on a nutator at 4 C. After washing the anti-Flag resin five
times with breaking buffer, bound complexes were eluted by using
breaking buffer containing 10% glycerol and 100 mg/mL Flag
peptide (Sigma), and the eluate was concentrated to 100 mL by
using a microcentricon YM-30 filter (Millipore). Purified proteins
were separated by SDS-PAGE and either stained with Coomassie
blue or transferred to nitrocellulose. Nitrocellulose filters were
blocked in 5% milk in 13 TBS, 0.1% Tween20 prior to incubation with anti c-myc 1:1000 (Roche), anti-Flag 1:600 (SigmaAldrich), or 2B1 1:10,000 (gift of Dr. Maurice Swanson, University of Florida, Gainesville), in 5% milk/13 TBS 1 h to overnight
at 4 C. Secondary antibody, goat anti-mouse conjugated to horseradish peroxidase (Amersham), was incubated at 1:10,000 for 0.5–1
h in 5% milk in 13 TBS at room temperature. Blots were washed
after primary and secondary antibodies for 5 min, three times,
using 13 TBS, 0.1% Tween20 prior to detection using ECL (Amersham). The blot was stripped by using a protocol suggested by the
manufacturer (Amersham) prior to immunoblotting with additional antibodies.

Northern blot analysis
A plasmid containing the htRNA3Lys gene was obtained as a gift
from Anders Byström. The gene was cloned into the vector
YEplac112 (Gietz and Sugino 1988) as a HindIII/PstI fragment,
creating plasmid p241. Y146 was transformed with both p241 and
pESC-URA (Y274) or p230 (Y275). The pESC-URA plasmid was
selected against in Y274 on 5-fluoroorotic acid (5-FOA) and the
5-FOA–resistant colonies transformed with TRM6 in YCplac33
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(p129) (Anderson et al. 1998). Yeast strains were grown in 50 mL
selective SCgal/raf at 30 C to OD600 1.2–1.6. Total RNA was
prepared as described (Varshney et al. 1991) but adjusted for
yeast cultures. tRNA was deacylated with 2 M Tris (pH 8) at
37 C for 30 min, precipitated, and resuspended in diethylpyrocarbonate (DEPC)-treated water. Sample concentrations were
determined by measuring the absorbance at 260 nm, and 5 mg
of samples was separated on a 5% polyacrylamide gel as described
(Varshney et al. 1991). RNA was transferred to Biodyne B (Pall
Corp.) in 0.53 Tris Borate EDTA (TBE) using a Panther Semidry
Electroblotter (Owl) at 600 mA for 1 h. Probes for htRNA3Lys,
JA141 (50 -CTGGACCCTCAGA), tRNAiMet, JA11 (50 -TCGGTTTCG
ATCCGAGGACATCAGGGTTATGA), or tRNALeu(CAA), JA151
(50 -TGGTTGCTAAGAGATTCGAAC), were made by incubating
10 pmol of the oligonucleotide with 50 mCi (g-32P) ATP (GE
Healthcare) and T4 polynucleotide kinase (New England Biolabs)
at 37 C for 1 h. Probes were separated from unincorporated
(g-32P) ATP by one pass through a 1-mL G-25 column equilibrated with water. Hybridization was carried out overnight in 0.25
M Na2HPO4 (pH 7.5), 1 mM EDTA, 1% BSA, and 7% SDS, and
results were visualized by autoradiography.

Mtase activity assay
Mtase activity assays of purified human enzyme were conducted
as described (Anderson et al. 2000) by using an optimized 13
Mtase buffer (100 mM Tris [pH 7.6], 0.1 mM EDTA, 10 mM
MgCl2, 100 mM NH4Cl, 1 mM DTT). A plasmid containing yeast
tRNAiMet (HG300, described in Senger et al. 1992) was obtained
as a gift from Dr. Henri Grosjean (CNRS, Gif-sur-Yvette, France).
The A58U tRNAiMet mutant plasmid (p324) was created in
HG300 using the QuikChange XL site-directed mutagenesis kit
(Stratagene) and oligos JA318 (50 -GTCCTCGGATCGTAACCGA
GCGGCGC) and JA319 (50 -CGCCGCTCGGTTACGATCCGAGG
AC). The A58U mutation was confirmed by DNA sequencing.
These plasmids were digested with BstNI and transcribed in vitro
using T7 RNA polymerase; as a control, the pTRI-RNA 18S antisense control template (Ambion) was also transcribed. Transcribed
RNAs were phenol extracted, ethanol precipitated, and quantitiated
using ethidium bromide staining after agarose gel electrophoresis by
comparison to known amounts of tRNAPhe from Escherichia coli
(Sigma-Aldrich). Before use in Mtase assays, RNAs were renatured
by first heating to 90 C for 1 min and 60 C for 15 min, and then
cooling to 30 C. Once at 30 C, samples were brought to 2.5 mM
MgCl2 and incubated at 30 C for 15 additional minutes, and then
placed on ice until being used in an Mtase assay. Activity assays were
carried out at 30 C for 10 min using 30 mM 3H-AdoMet, 150 nM
RNA substrate, and 15 nM purified enzyme. Radioactivity incorporated into the substrate RNAs was measured by liquid scintillation as previously described (Anderson et al. 1998) using BetaMax
scintillation cocktail (ICN Biomedical).
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